This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Ajou University Industry-Academic Cooperation Foundation, Genesen Co., Ltd., University-Industry Cooperation Group of Kyung Hee University. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 386 
1 out of 3 
1 out of 638 Years Active: 2019-2026
Title: Sang Dun Choi: Innovator in Pharmaceutical Composition and Stem Cell Recruitment
Introduction
Sang Dun Choi is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative peptides and analogs that target various biological pathways. With a total of 4 patents, his work has the potential to impact the treatment of autoimmune and inflammatory diseases.
Latest Patents
One of his latest patents is focused on a peptide for toll-like receptor (TLR) inhibition and a pharmaceutical composition comprising the same. This invention relates to a fusion polypeptide that inhibits TLR1/2, TLR2/6, TLR7, TLR8, and TLR9 signaling pathways, as well as Toll-like receptor 4 (TLR4) and TLR3. The fusion peptide demonstrates an excellent effect in inhibiting TLR4 and various TLR pathways, making it effective for preventing and treating diseases mediated by these pathways, such as autoimmune and degenerative neurological diseases.
Another significant patent involves a substance P analog that has progenitor cell or stem cell recruiting activity. This invention describes a method for recruiting progenitor cells or stem cells using the substance P analog. The analog effectively recruits endogenous progenitor cells or stem cells to sites of wounds or diseases, offering potential applications in regenerating or treating damaged organs or tissues.
Career Highlights
Sang Dun Choi has worked with prominent organizations, including the Ajou University Industry-Academic Cooperation Foundation and Genesen Co., Ltd. His experience in these institutions has allowed him to collaborate on various innovative projects that bridge academia and industry.
Collaborations
He has collaborated with notable individuals in his field, including Hyuk Kwon Kwon and Hyeon Jun Shin. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Sang Dun Choi is a distinguished inventor whose work in pharmaceutical compositions and stem cell recruitment holds promise for advancing medical treatments. His innovative approaches to inhibiting TLR pathways and recruiting stem cells are paving the way for new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile